ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,599Medicare Part D Prescriptions Filled, Including Refills

Rank: 3 out of 178

$547K Total Retail Price of All Prescriptions

Rank: 9 out of 178

369 Patients Receiving at Least One Drug in Part D
96%Patients 65 Years and Older
54% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in District of Columbia
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 369 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

9% of this provider’s 369 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

0% of this provider’s 10,253 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $77 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in District of Columbia
SIMVASTATIN 481 477 1 3
LISINOPRIL 374 347 2 2
AMLODIPINE BESYLATE 367 349 3 1
LEVOTHYROXINE SODIUM 317 317 4 8
SERTRALINE HCL 303 296 5 32
DONEPEZIL HCL 292 284 6 29
FUROSEMIDE 269 265 7 6
METOPROLOL TARTRATE 252 252 8 10
RANITIDINE HCL 207 207 9 39
METOPROLOL SUCCINATE 198 193 10 11
MIRTAZAPINE 197 197 11 47
OMEPRAZOLE 166 164 12 9
WARFARIN SODIUM 160 160 13 15
RISPERIDONE 151 151 14 61
LOSARTAN POTASSIUM 150 137 15 12
POTASSIUM CHLORIDE 149 149 16 43
POLYETHYLENE GLYCOL 3350 149 148 16 60
HYDROCHLOROTHIAZIDE 147 135 18 5
LANTUS 133 128 19 26
ZOLPIDEM TARTRATE 132 131 20 16
PANTOPRAZOLE SODIUM 130 130 21 42
HYDROCODONE-ACETAMINOPHEN 127 127 S3 22 37
ATORVASTATIN CALCIUM 122 118 23 4
TAMSULOSIN HCL 121 121 24 40
METFORMIN HCL 120 91 25 7
GABAPENTIN 116 106 26 14
NAMENDA 113 108 27 53
TRAZODONE HCL 105 105 28 57
CARVEDILOL 90 88 29 27
ATENOLOL 87 87 30 13
OLANZAPINE 86 86 31 94
ESCITALOPRAM OXALATE 84 84 32 114
PROCRIT 82 82 33 138
BUPROPION HCL 75 75 34 142
DIOVAN 73 73 35 23
CLOPIDOGREL 72 72 36 36
QUETIAPINE FUMARATE 72 72 36 59
PLAVIX 71 71 38 54
CARBIDOPA-LEVODOPA 70 70 39 144
ALENDRONATE SODIUM 67 67 40 33
OXYCODONE-ACETAMINOPHEN 66 52 S2 41 31
LATANOPROST 62 62 42 77
LIDODERM 60 60 43 159
ADVAIR DISKUS 58 58 44 46
CYMBALTA 57 50 45 122
TRAVATAN Z 53 48 46 134
CIPROFLOXACIN HCL 52 52 47 119
TRIAMTERENE-HYDROCHLOROTHIAZID 51 51 48 185
DIVALPROEX SODIUM 51 48 48 95
DIGOXIN 50 50 50 105
SPIRIVA 50 50 50 65
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 25, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.